Levocarnitine for Chemotherapy Fatigue in Cancer Patients
Author Information
Author(s): Graziano F, Bisonni R, Catalano V, Silva R, Rovidati S, Mencarini E, Ferraro B, Canestrari F, Baldelli A M, De Gaetano A, Giordani P, Testa E, Lai V
Primary Institution: Medical Oncology Unit, Hospital of Urbino, Italy
Hypothesis
Can levocarnitine supplementation improve chemotherapy-induced fatigue in non-anaemic cancer patients?
Conclusion
Levocarnitine supplementation may effectively alleviate chemotherapy-induced fatigue in non-anaemic cancer patients.
Supporting Evidence
- Fatigue improved in 90% of patients after 1 week of treatment.
- All patients achieved normal plasma carnitine levels after supplementation.
- The mean FACT-F score increased significantly from 19.7 to 34.9 after treatment.
Takeaway
This study found that giving cancer patients a supplement called levocarnitine helped them feel less tired after chemotherapy.
Methodology
Patients received oral levocarnitine 4 g daily for 7 days and fatigue was assessed using the FACT-F questionnaire.
Potential Biases
Potential biases due to the lack of randomization and the specific patient selection criteria.
Limitations
The study did not include a control group for comparison and was conducted in a homogenous patient population.
Participant Demographics
Non-anaemic cancer patients undergoing chemotherapy, with a performance status of 0-1.
Statistical Information
P-Value
<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website